Dr. Reesink’s laboratory aims to unravel basic mechanisms underlying the development of orthopedic disease and to pioneer innovative therapies for the treatment of joint injury and arthritis in equine and human athletes. The lab is broadly interested in the use of regenerative medicine, including the use of stem cell therapy and secreted molecules, for the treatment of musculoskeletal disease. An area of active investigation is understanding how the glycoprotein lubricin protects against joint disease and how lubricin therapy may be employed to prevent additional cartilage damage and ameliorate arthritis.
